Our and other earlier studies have established that HIF-1 promotes glycolysis and de novo lipogenesis and inhibits FAO in HCC, and STIM1-mediated SOCE stabilizes HIF-1α 9, 36-38. Here, HIF1A is linked to hepatocellular carcinoma.